CANON MEDICAL | Oncology days | Liver Cancer Imaging

3 Views
administrator
administrator
07/13/23

00:00 Welcome
01:44 Introduction
02:15 Dr. Ewoud Smit | The Current and Future Role of CT in Liver Cancer Imaging
18:09 Introduction
18:25 Dr. Benoit Sauer | Liver Cancer Diagnosis with MRI
33:59 Introduction
34:35 Dr. Mark Burgmans | CT Volumetry to Plan and Evaluate Percutaneous Treatment of HCC
54:42 Q&A

The liver is a common site of metastatic spread, especially tumors from the colon, lung, pancreas and stomach, and in patients with chronic liver disease who are at risk for developing hepatocellular carcinoma. Both CT and MRI have a major role to play in all stages of this disease, from diagnosis, staging and treatment planning to follow-up. During this webinar, experts will guide you through all the possibilities in liver cancer imaging to maximize the image quality and enable clinicians to better treat this challenging disease.

Channel link: https://www.youtube.com/CanonMedicalEU
Website link: https://eu.medical.canon/
https://eu.medical.canon/events_calendar/webinars/

Connect with us on
Facebook: https://www.facebook.com/CanonMedicalEU
Twitter: https://twitter.com/CanonMedicalEU
LinkedIn: https://www.linkedin.com/company/canon-medical-eu

Disclaimers
• The opinions expressed in this material are solely those of the presenter and not necessarily those of Canon Medical Systems. Canon Medical Systems does not guarantee the accuracy or reliability of the information provided herein.

• The clinical results, performance and views described in this video/webinar are the experience of the clinician. Results may vary due to clinical setting, patient presentation and other factors. Many factors could cause the actual results and performance of Canon Medical’s products to be materially different from any of the aforementioned.

• Some products shown might not be available in all regulatory jurisdictions, please consult with your local Canon sales office for availability in your region.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next